Here are the latest quarterly results of TORRENT PHARMA. For more details, see the TORRENT PHARMA financial fact sheet and TORRENT PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 21,310 | 23,470 | 22,910 | 24,910 | 24,910 | 25,910 | 26,600 | 27,320 | |
Other income | Rs m | 560 | 300 | 160 | -100 | 90 | 340 | 260 | -330 | |
Turnover | Rs m | 21,870 | 23,770 | 23,070 | 24,810 | 25,000 | 26,250 | 26,860 | 26,990 | |
Expenses | Rs m | 15,700 | 16,350 | 16,120 | 17,670 | 17,640 | 18,000 | 18,350 | 18,630 | |
Gross profit | Rs m | 760 | 7,120 | 6,790 | 7,240 | 7,270 | 7,910 | 8,250 | 9,570 | |
Depreciation | Rs m | 1,620 | 1,550 | 1,630 | 1,930 | 1,960 | 1,910 | 2,010 | 2,130 | |
Interest | Rs m | 570 | 550 | 690 | 1,020 | 1,070 | 1,030 | 910 | 800 | |
Profit before tax | Rs m | -870 | 5,320 | 4,630 | 4,190 | 4,330 | 5,310 | 5,590 | 6,310 | |
Tax | Rs m | 310 | 1,780 | 1,510 | 1,270 | 1,460 | 1,530 | 1,730 | 1,880 | |
Profit after tax | Rs m | -1,180 | 3,540 | 3,120 | 2,920 | 2,870 | 3,780 | 3,860 | 4,430 | |
Gross profit margin | % | 3.6 | 30.3 | 29.6 | 29.1 | 29.2 | 30.5 | 31.0 | 35.0 | |
Effective tax rate | % | -35.6 | 33.5 | 32.6 | 30.3 | 33.7 | 28.8 | 30.9 | 29.8 | |
Net profit margin | % | -5.5 | 15.1 | 13.6 | 11.7 | 11.5 | 14.6 | 14.5 | 16.2 | |
Diluted EPS | Rs | -3.5 | 10.5 | 9.2 | 8.6 | 8.5 | 11.2 | 11.4 | 13.1 | |
Diluted EPS (TTM) | Rs | 23.0 | 23.7 | 23.5 | 24.8 | 36.8 | 37.5 | 39.7 | 44.1 | |
Subscriber Feature |
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.